Must Read Articles

Are Small-Format Drug Conjugates a Viable ADC Alternative Solid Tumors?

Antibody-drug conjugates or ADCs are complex immunoconjugates. They are designed to selectively deliver a small-molecules cytotoxic payload to cancer...

New Hydrophilic Auristatin Payload Improves Antibody-Drug Conjugate Efficacy and Biocompatibility

Antibody-drug conjugates or ADCs, which link an antibody to a potent, small-molecule, cytotoxic, cell-killing, chemotherapeutic agent, use the target-specificity...

Eric Rosenthal Reports: Why Academia Wasn’t Ready to Build Big Data Systems

Big news hit the pharmaceutical industry in February when Roche Pharmaceuticals announced that it would be acquiring big-data firm...

Study Shows Concentration of Intratumoral Payload Correlates with ADC Activity

A study published in the March 2018 edition of Molecular Cancer Therapeutics shows that, while antibody–drug conjugates or ADC...

Phase III ECHELON-1 Clinical Trial of Brentuximab Vedotin Meets Primary Endpoint – Demonstrates a...

Data from the Phase III ECHELON-1 clinical trial evaluating brentuximab vedotin (Adcetris®; Seattle Genetics | Takeda) as part of...

Market Trend: Cancer Immunotherapy Destined for Growth

According to data provided by Allied Market Research, the global cancer immunotherapy market is expected to grow to $117.14...

What Happens when the World of Pharma Returns to Frankfurt?

In October 2017 the 28th CPhI Worldwide returns to Frankfurt, Germany. This event takes place in a year where...

Simplifying the Development of Site-specific Antibody-drugs Conjugates

Research by Rice University scientists, supported by the National Science Foundation and the Robert A. Welch Foundation, shows the...

A Simple Approach to the Registration of Antibody Drug Conjugates

Over the last two decades, Antibody-drug Conjugates (ADC) have become a major area of interest for an expanded pipeline...

Registration of Antibody Drug Conjugates

Abstract      Antibody Drug Conjugates (ADC) are a rapidly expanding area of pharma company pipelines. They combine the targeting of...